The effect of Obstructive Sleep Apnoea (OSA) and its treatment with Continuous Positive Airways Pressure (CPAP) on arterial stiffness.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000356662

Acronym

AIX OSA

Enrollment

Registered

2005-09-09

Start date

2005-10-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Subjects with OSA will be studied before and after 2 months treatment with nasal Continuos Postive Airway Pressure (CPAP) therapy. Subjects will undergo measurement of arterial stiffness using the technique of Pulse Wave Analysis before and after treatment with CPAP.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

21 Years to 65 Years

Healthy volunteers

Inclusion criteria

1. BMI 40 2. Must be able to read and speak English.

Exclusion criteria

Clinically significant co morbidity, including any unstable cardiovascular, gastrointestinal, metabolic, pulmonary (e.g., asthma, COPD), renal, neurological, hepatic, hematologic, immunologic, endocrine, psychiatric illness and/or neoplastic disease based on Principal Investigator judgment.

Outcome results